By acquiring the shares in Beijing Skywing Technology Co. Ltd., Beijing, China, in early 2011, the Merck Millipore division expanded its business in the Process Solutions business unit to include a leading supplier to the biopharmaceutical sector in China. In addition, in March 2011 the division acquired the industrial microbiology business of Biotest AG, based in Dreieich, Germany. The activities of Biotest were integrated into the Lab Solutions business unit and have expanded the portfolio of biomonitoring test systems. The acquisition of Amnis Corporation based in Seattle, Washington (USA), which was announced in August 2011, closed in the fourth quarter of 2011. Amnis is a manufacturer of flow cytometry instruments for cell analysis and has been assigned to the BioScience business unit.
Print this page